GHK-Cu research
GHK is a naturally occurring copper-binding tripeptide. Laboratory and preclinical literature has explored extracellular-matrix remodeling, collagen-related pathways, wound biology and skin-cell signaling. Reviews note cosmetic interest but also emphasize that rigorous clinical evidence for many proposed effects remains limited.
BPC-157 research
BPC-157 has a large preclinical literature involving tissue injury, gastrointestinal models, inflammatory signaling and musculoskeletal repair. Recent reviews emphasize a major translational gap: human evidence remains extremely limited, no FDA-approved formulation exists, and validated clinical dosing has not been established.
TB-500 / thymosin-beta research
Thymosin beta-4 is a naturally occurring actin-binding peptide with research related to cell migration, angiogenesis and tissue repair. Commercial products called TB-500 are not automatically interchangeable with the thymosin beta-4 preparations used in published studies, so claims should not treat those terms as identical.
What can responsibly be said about the blend
The components connect to active areas of skin, connective-tissue and repair-pathway research. What cannot responsibly be claimed is that the BBG70 combination is proven to accelerate healing, reverse aging, increase collagen in humans, or treat injury. Combination-specific human trials are lacking.